Bill Milgram
President and CEO
Business and Management
CANCOM a+d IT Solutions GmbH
Canada
Biography
Dr. Milgram is a co-founder of CanCog Technologies and the world's leading expert in the field of canine cognitive aging. He was instrumental in the successful development of Anipryl as an animal pharmaceutical licensed to Pfizer for treatment of Cognitive Dysfunction Syndrome in Dogs. More recently, Dr. Milgram has assisted in the development of the ProPlan Senior 7+ diet for dogs, Nutricks (cognitive dysfunction) and Sin Susto as an anxiolytic. Dr. Milgram's scientific qualification include over 150 refereed publications, over 100 abstracts, 2 edited books and 8 book chapters. He has also been a consultant to several animal health and pet food companies. Dr. Milgram has a PhD in behavioral Neuroscience from McGill University, is a professor emeritus at the University of Toronto and currently holds an appointment in the department of Pharmacology at the University of Toronto.
Research Interest
Pharmacology
